Meridian Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
Meridian Bioscience Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Meridian Bioscience's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | Buy/Sell | $591.94 | 8.32% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF217.30 | Buy/Sell | CHF307.83 | 25.40% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$248.38 | Buy/Sell | $260.33 | 9.68% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.90 | Buy/Sell | $118.92 | 18.04% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
177.62€ | Buy/Sell | 178.14€ | 10.07% |
Meridian Bioscience Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Meridian Bioscience's Revenue has grown, rising from $253.67M to $333.02M – a growth of 31.28%. In the following year, the 0 analysts surveyed believe that Meridian Bioscience's Revenue will decrease by 9.76%, reaching $300.52M. According to professionals, by 2030, Meridian Bioscience's Revenue will have decreased by 9.19%, falling down to $302.42M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$234.68 | Buy/Sell | $284.47 | 18.25% |
| ILMN Stock Forecast | Illumina | Outperform |
16
|
$117.93 | Buy/Sell | $159.28 | 22.95% |
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
98.70€ | Buy/Sell | 105.55€ | 15.50% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TECH Stock Forecast | Bio-Techne Corp | Buy |
16
|
$77.29 | Buy/Sell | $100.78 | 8.68% |
| MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$19.47 | Buy/Sell | $22.08 | 28.40% |
| OSUR Stock Forecast | OraSure Technologies | Hold |
11
|
$5.49 | Buy/Sell | $7.40 | 32.06% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BCART Stock Forecast | Biocartis Group NV | - |
7
|
0.29€ | Buy/Sell | 1.10€ | -100.00% |
| TRIB Stock Forecast | Trinity Biotech | - |
0
|
$1.80 | Buy/Sell | $3.00 | -100.00% |
| AXDX Stock Forecast | Accelerate Diagnostics | Buy |
8
|
$0.92 | Buy/Sell | $5.00 | -100.00% |
Meridian Bioscience EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Meridian Bioscience's EBITDA has grown by 22.39%, rising from $75.26M to $92.11M. For the next year, analysts predict that EBITDA will reach $97.35M – an increase of 5.69%. Over the next eight years, experts believe that Meridian Bioscience's EBITDA will grow at a rate of 6.11%.
Meridian Bioscience EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Meridian Bioscience's EBIT has grown, moving from $61.69M to $75.60M – an increase of 22.55%. In the next year, analysts predict that EBIT will jump to $82.68M – up 9.37% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 10.13%.
Meridian Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Meridian Bioscience's EPS has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
.jpg)